Segall Bryant & Hamill LLC Cuts Stock Holdings in Surgery Partners, Inc. (NASDAQ:SGRY)

Segall Bryant & Hamill LLC lessened its stake in Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 50.4% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 148,433 shares of the company's stock after selling 151,005 shares during the quarter. Segall Bryant & Hamill LLC owned 0.12% of Surgery Partners worth $3,525,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in the business. DekaBank Deutsche Girozentrale bought a new stake in Surgery Partners during the first quarter worth $65,000. State of Wyoming raised its position in Surgery Partners by 94.4% during the fourth quarter. State of Wyoming now owns 4,002 shares of the company's stock worth $85,000 after acquiring an additional 1,943 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. raised its position in Surgery Partners by 12.1% during the fourth quarter. Point72 Asia Singapore Pte. Ltd. now owns 4,296 shares of the company's stock worth $91,000 after acquiring an additional 465 shares in the last quarter. GAMMA Investing LLC raised its position in Surgery Partners by 7,902.7% during the first quarter. GAMMA Investing LLC now owns 8,883 shares of the company's stock worth $211,000 after acquiring an additional 8,772 shares in the last quarter. Finally, Tower Research Capital LLC TRC raised its position in Surgery Partners by 279.3% during the fourth quarter. Tower Research Capital LLC TRC now owns 10,762 shares of the company's stock worth $228,000 after acquiring an additional 7,925 shares in the last quarter.

Surgery Partners Stock Performance

Shares of SGRY stock traded down $0.30 on Friday, hitting $22.32. The company's stock had a trading volume of 1,473,966 shares, compared to its average volume of 1,200,468. The company has a market capitalization of $2.86 billion, a PE ratio of -14.59 and a beta of 1.90. The company has a debt-to-equity ratio of 1.09, a quick ratio of 1.73 and a current ratio of 1.89. Surgery Partners, Inc. has a fifty-two week low of $18.87 and a fifty-two week high of $33.97. The stock's 50 day moving average is $22.43 and its 200-day moving average is $22.80.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last announced its quarterly earnings data on Monday, May 12th. The company reported $0.04 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.08 by ($0.04). The firm had revenue of $776.00 million for the quarter, compared to analyst estimates of $777.77 million. Surgery Partners had a positive return on equity of 2.41% and a negative net margin of 6.10%. The company's quarterly revenue was up 8.2% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.10 earnings per share. Equities research analysts expect that Surgery Partners, Inc. will post 0.67 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the stock. Barclays dropped their price objective on shares of Surgery Partners from $25.00 to $24.00 and set an "equal weight" rating on the stock in a research report on Tuesday, May 27th. Royal Bank Of Canada reissued an "outperform" rating and issued a $35.00 price objective on shares of Surgery Partners in a research report on Tuesday, March 25th. Finally, Benchmark reissued a "buy" rating and issued a $35.00 price objective on shares of Surgery Partners in a research report on Monday, April 21st. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $33.56.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.